IP Library Patent Application 17329616
Patent Application
App. No. 17/329,616

DETECTION OF COLORECTAL CANCER

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/329,616
Abstract

The present disclosure provides, among other things, methods for colorectal cancer screening and compositions related thereto. In various embodiments, the present disclosure provides methods for colorectal cancer screening that include analysis of methylation status of one or more methylation biomarkers, and compositions related thereto. In various embodiments, the present disclosure provides methods for colorectal cancer screening that include screening methylation status of one or more methylation biomarkers in cfDNA, e.g., in ctDNA. In various embodiments, the present disclosure provides methods for colorectal cancer screening that include screening methylation status of one or more methylation biomarkers in cfDNA, e.g., in ctDNA, using MSRE-qPCR.

Claims (10)

1 .- 30 . (canceled)

31 . A kit for use in colorectal cancer screening, the kit comprising:

at least one oligonucleotide primer pair for amplification of a methylation locus within a differentially methylated region (DMR) of one or more of the genes according to Table 13.

32 . (canceled)

33 . The kit of claim 31 , wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558 and FGF14 '577.

34 . The kit of claim 31 , wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558, FGF14 '577, and PDGFD ‘388.

35 . The kit of claim 31 , wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558, FGF14 '577, PDGFD ‘388, ZNF471 '527, and ADAMTS2 '284.

36 . The kit of claim 31 , wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558, FGF14 '577, PDGFD ‘388, ZNF471 '527, ADAMTS2 '284, ADAMTS2 '254, ZNF492 '069, and ST6GALNAC5 '456.

37 . The kit of claim 31 , wherein the oligonucleotide primer pairs include oligonucleotide primer pairs for amplification of DMRs ZNF471 '558, FGF14 '577, PDGFD ‘388, ZNF471 '527, ADAMTS2 '284, ADAMTS2 '254, ZNF492 '069, ST6GALNAC5 '456, ZNF542 '502, LONRF2 '281, ZNF132 '415, PDGFD ‘921, ZNF132 '268, CNRIP1 '272, and ALK ‘434.

38 .- 41 . (canceled)

Assignments (4)
CHANGE OF NAME Recorded Aug 1, 2023
From: UNIVERSAL DIAGNOSTICS, S.L.
To: UNIVERSAL DIAGNOSTICS, S.A.
Reel/Frame 064461/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2021
From: BITENC, MARKO; KRUUSMAA, KRISTI; MARTINEZ-BAREA, JUAN; HENSE, CHRISTIAN
To: UNIVERSAL DIAGNOSTICS, S.L.
Reel/Frame 056362/0533 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2021
From: CHERSICOLA, MARKO; KNAP, PRIMO?
To: GENEPLANET D.O.O.
Reel/Frame 056362/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2021
From: GENEPLANET D.O.O.
To: UNIVERSAL DIAGNOSTICS, S.L.
Reel/Frame 056362/0578 →